Por favor, use este identificador para citar o enlazar este Item:http://hdl.handle.net/20.500.12105/6831
Título
Cefditoren and ceftriaxone enhance complement-mediated immunity in the presence of specific antibodies against antibiotic-resistant pneumococcal strains
Autor(es)
Ramos-Sevillano, Elisa ISCIII | Rodriguez-Sosa, Cinthya ISCIII | Cafini, Fabio | Giménez, Maria-Jose | Navarro, Ana ISCIII | Sevillano, David | Alou, Luis | García, Ernesto | Aguilar, Lorenzo | Yuste, Jose Enrique ISCIII
Fecha de publicación
2012-09-05
Cita
PLoS One. 2012;7(9):e44135
Idioma
Inglés
Tipo de documento
journal article
Resumen
BACKGROUND: Specific antibodies mediate humoral and cellular protection against invading pathogens such as Streptococcus pneumoniae by activating complement mediated immunity, promoting phagocytosis and stimulating bacterial clearance. The emergence of pneumococcal strains with high levels of antibiotic resistance is of great concern worldwide and a serious threat for public health. METHODOLOGY/PRINCIPAL FINDINGS: Flow cytometry was used to determine whether complement-mediated immunity against three antibiotic-resistant S. pneumoniae clinical isolates is enhanced in the presence of sub-inhibitory concentrations of cefditoren and ceftriaxone. The binding of acute phase proteins such as C-reactive protein and serum amyloid P component, and of complement component C1q, to pneumococci was enhanced in the presence of serum plus either of these antibiotics. Both antibiotics therefore trigger the activation of the classical complement pathway against S. pneumoniae. C3b deposition was also increased in the presence of specific anti-pneumococcal antibodies and sub-inhibitory concentrations of cefditoren and ceftriaxone confirming that the presence of these antibiotics enhances complement-mediated immunity to S. pneumoniae. CONCLUSIONS/SIGNIFICANCE: Using cefditoren and ceftriaxone to promote the binding of acute phase proteins and C1q to pneumococci, and to increase C3b deposition, when anti-pneumococcal antibodies are present, might help reduce the impact of antibiotic resistance in S. pneumoniae infections.
MESH
Acute-Phase Proteins | Animals | Anti-Bacterial Agents | Antibodies | Ceftriaxone | Cephalosporins | Complement Activation | Complement C1q | Complement C3c | Drug Resistance, Microbial | Egtazic Acid | Flow Cytometry | Humans | Immune System | Mice | Phagocytosis | Streptococcus pneumoniae | beta-Lactams
Versión en línea
DOI
Aparece en las colecciones